A phase I study with an expansion cohort of duvelisib and nivolumab in mycosis fungoides (MF) and Sezary syndrome (SS)
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Principal Investigator
Brad Haverkos, MD
Study ID
Protocol Number: 21-4327
More information available at ClinicalTrials.gov: NCT04652960
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers